A factor of anti-atherosclerotic activity-fibrinolytic activity of venom of Buthus tumulus species (Indian red scorpion)
Introduction: Atherosclerosis (AS) is an inflammatory disease of the arterial blood vessels (arteries), in which the walls of the blood vessels become thickened and hardened specifically due to atheromatous plaques. The plaques are composed of cholesterol and other lipids, inflammatory cells, and calcium deposits. There are five different types of atherosclerosis such as in the aorta, coronary, cerebral, renal, and pulmonary arteries. The scorpion species that present medical importance belonging to the family Buthidae Scorpion toxins consist of several peptides isolated from the venom of different species of scorpion and are based on their pharmacological action and also agree well with the structural properties of this peptide family.
Method: The study was conducted in the Department of Pharmacology, Modern College of Pharmacy, Nigadi, Pune in the year June 2012- June-2013 by In-vitro blood clot dissolving activity of SV and artificial blood clot degradation method
Results: It was observed that SV was evaluated for its fibrinolytic properties in the In-vitro blood clot dissolving method and shown to decrease the stained area of the blood-stained cloth as compared to the control.
Conclusion: In the artificial blood clot degradation method, the color intensity is higher in the test tube containing SV compared to the control and hence, it can be stated that SV has fibrinolytic activity.
Abbott, R. D., Launer, L. J., Rodriguez, B. L., Ross, G. W., Wilson, P. W., Masaki, K. H., Strozyk, D., Curb, J. D., Yano, K., Popper, J. S., & Petrovitch, H. (2007). Serum estradiol and risk of stroke in elderly men. Neurology, 68(8), 563–568.
Bai L.X., Guangjin L.Z., Ying Z., Yanping D. (1994). Effect of Scorpion and Bee Venom Peptide (SBP) on Fibrinolytic System in Rat, (Institute of Cardiovascular Pharmacology Wei Fang Medical College, Basic Medical Sciences and Clinics, 4.
Bjornholt J.V., Erikssen G., Aaser E., Sandvik L., Nitter-Hauge S., Jervell J., Erikssen J., (2012). Venom with strong ﬁbrinolytic activity, Toxicon, 60: 70–82.
Cerit L. (2017). Fibrinogen and Atherosclerosis. Arquivos brasileiros de cardiologia, 108(2), 189–190.
Hariprasad, G., Kumar, M., Srinivasan, A., Kaur, P., Singh, T. P., & Jithesh, O. (2011). Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: Targeting and reversible inhibition by native peptides. International journal of biological macromolecules, 48(3), 423–431.
Levenson, J., Giral, P., Razavian, M., Gariepy, J., & Simon, A. (1995). Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors. Arteriosclerosis, thrombosis, and vascular biology, 15(9), 1263–1268.
Müller G. J. (1993). Scorpionism in South Africa. A report of 42 serious scorpion envenomations. South African medical journal Suid-Afrikaanse tydskrif vir geneeskunde, 83(6), 405–411.
Petricevich, V. L., Hernández Cruz, A., Coronas, F. I., & Possani, L. D. (2007). Toxin gamma from Tityus serrulatus scorpion venom plays an essential role in immunomodulation of macrophages. Toxicon: official journal of the International Society on Toxinology, 50(5), 666–675.
Possani, L. D., Becerril, B., Delepierre, M., & Tytgat, J. (1999). Scorpion toxins specific for Na+-channels. European journal of biochemistry, 264(2), 287–300.
Possani, L. D., Merino, E., Corona, M., Bolivar, F., & Becerril, B. (2000). Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie, 82(9-10), 861–868.
Ross Russell .D. (1999). Atherosclerosis- An Inflammatory disease,Mechanism of Disease 340:115-126, Russell F.E, toxic effects of terrestrial animal venoms and poisons, chapter 26, Unit-948.
Wheeler, K. P., Barhanin, J., & Lazdunski, M. (1982). Specific binding of toxin II from Centruroides suffusus suffusus to the sodium channel in electroplaque membranes. Biochemistry, 21(22), 5628–5634.
Wig, K. L., Malhotra, R. P., Chitkara, N. L., & Gupta, S. P. (1962). Prevalence of coronary atherosclerosis in northern India. British medical journal, 1(5277), 510–513.
Copyright (c) 2023 Renuka Bhoi
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.